Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Molina Healthcare's fourth-quarter and full-year 2024 results present a mixed picture, reflecting both challenges and prospects for future growth.</li><li>The company reported an adjusted EPS of $5.05 for the fourth quarter and $22.65 for the full year, which represents an 8.5% year-over-year growth.</li><li>However, the fourth-quarter results did not meet the company's internal expectations due to higher-than-anticipated medical cost pressure in the Medicaid and Medicare segments, leading to a consolidated medical care ratio (MCR) of 90.2% for the quarter, which was above forecasts.</li></ul>

Molina Healthcare's fourth-quarter and full-year 2024 results present a mixed picture, reflecting both challenges and prospects for future growth.The company reported an adjusted EPS of $5.05 for the fourth quarter and $22.65 for the full year, which represents an 8.5% year-over-year growth.However, the fourth-quarter results did not meet the company's internal expectations due to higher-than-anticipated medical cost pressure in the Medicaid and Medicare segments, leading to a consolidated medical care ratio (MCR) of 90.2% for the quarter, which was above forecasts.

Molina Healthcare’s Medical Cost Crisis – How They’re Fighting Back!

External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

<ul><li>Molina offers Managed Medicaid services to low-income individuals on behalf of state governments, receiving a fixed fee per member in exchange for assuming medical risk, managing provider networks, and administering the program</li><li>The company operates in a competitive landscape with few key players in the Managed Medicaid market, giving them an advantage when states put their programs out to bid</li><li>Molina's successful business model effectively manages Medicaid programs while minimizing risk for state administrators</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Molina offers Managed Medicaid services to low-income individuals on behalf of state governments, receiving a fixed fee per member in exchange for assuming medical risk, managing provider networks, and administering the programThe company operates in a competitive landscape with few key players in the Managed Medicaid market, giving them an advantage when states put their programs out to bidMolina's successful business model effectively manages Medicaid programs while minimizing risk for state administratorsThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Molina Healthcare Inc (MOH) - Monday, Oct 28, 2024

<ul><li>Molina Healthcare's recent earnings report for the third quarter of 2024 reflects a mixed performance with certain financial achievements offset by ongoing challenges.</li><li>The company reported adjusted earnings per share of $6.01, aligning with expectations, on $9.7 billion of premium revenue.</li><li>Despite facing upward pressure on medical costs, resulting in a consolidated medical care ratio (MCR) of 89.2%, Molina Healthcare maintained a robust adjusted pre-tax margin of 4.5% (3.4% after tax), demonstrating a balanced business portfolio.</li></ul>

Molina Healthcare's recent earnings report for the third quarter of 2024 reflects a mixed performance with certain financial achievements offset by ongoing challenges.The company reported adjusted earnings per share of $6.01, aligning with expectations, on $9.7 billion of premium revenue.Despite facing upward pressure on medical costs, resulting in a consolidated medical care ratio (MCR) of 89.2%, Molina Healthcare maintained a robust adjusted pre-tax margin of 4.5% (3.4% after tax), demonstrating a balanced business portfolio.

Molina Healthcare Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! - Major Drivers

<ul><li>Molina Healthcare has reported their first quarter earnings, achieving an adjusted EPS of $5.73 and generating $9.5 billion in premium revenue.</li><li>The company’s performance was described as being in line with expectations and is backed by efficient operating metrics across all business segments.</li><li>The consolidated MCR (medical cost ratio) stood at 88.5%, demonstrating strong medical cost management with results across segments fulfilling the company's forecasts.</li></ul>

Molina Healthcare has reported their first quarter earnings, achieving an adjusted EPS of $5.73 and generating $9.5 billion in premium revenue.The company’s performance was described as being in line with expectations and is backed by efficient operating metrics across all business segments.The consolidated MCR (medical cost ratio) stood at 88.5%, demonstrating strong medical cost management with results across segments fulfilling the company's forecasts.

Molina Healthcare Inc.: Initiation of Coverage - A Story Of Enhanced Focus on Managed Medicaid and Medicare Advantage Expansion! - Major Drivers

Junior Finance Analyst, Steno Research

Ulrik Simmelholt

Junior Finance Analyst

Macro and Geopolitical Research House

Steno Research

Steno Research is a new macro and geopolitical research house. We are based out of Copenhagen, Denmark, but have an international team and a strong network of sources and partners around the world. The team is lead by Andreas Steno, previous global head of strategy at Nordea Bank, and Mikkel Rosenvold, former chief consultant in the Danish Ministry of Finance.

Cross Asset Strategy

<ul><li>We’ve received loads of feedback from our clients regarding our Trump versus Biden basket.</li><li>As a result, we will provide a detailed breakdown of both baskets and explain the rationale behind each.</li><li>We are updating the baskets regularly based on the political proposals of the two candidates.</li></ul>

We’ve received loads of feedback from our clients regarding our Trump versus Biden basket.As a result, we will provide a detailed breakdown of both baskets and explain the rationale behind each.We are updating the baskets regularly based on the political proposals of the two candidates.

Equity Watch: The Trump versus Biden Basket

United States

Molina Healthcare Inc. is a managed care organization.  The Company arranges for the delivery of health care services to persons eligible for Medicaid and other programs for low-income families and individuals.  Molina Healthcare has health plans in California, Washington, Utah, and Michigan, as well as primary care clinics located in Northern and Southern California.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Molina Healthcare (MOH US)

Molina Healthcare’s Medical Cost Crisis – How They’re Fighting Back!

Molina Healthcare's fourth-quarter and full-year 2024 results present a mixed picture, reflecting both challenges and prospects for future...

Baptista Research

Molina Healthcare Inc (MOH) - Monday, Oct 28, 2024

The company operates in a competitive landscape with few key players in the Managed Medicaid market, giving them an advantage when states put their...

Value Investors Club

Molina Healthcare Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! - Major Drivers

Molina Healthcare's recent earnings report for the third quarter of 2024 reflects a mixed performance with certain financial achievements offset...

Baptista Research

Molina Healthcare Inc.: Initiation of Coverage - A Story Of Enhanced Focus on Managed Medicaid and Medicare Advantage Expansion! - Major Drivers

Molina Healthcare has reported their first quarter earnings, achieving an adjusted EPS of $5.73 and generating $9.5 billion in premium...

Baptista Research

Equity Watch: The Trump versus Biden Basket

We’ve received loads of feedback from our clients regarding our Trump versus Biden basket. As a result, we will provide a detailed breakdown of...

Steno Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)